I wish HALF as much pressure was put on the FDA fo
Post# of 405
Posted On: 10/31/2016 7:34:43 PM
I wish HALF as much pressure was put on the FDA for delaying approval for ANDA generics as director Comey is now under !
Supposed to create competition and lower Healthcare costs, right ? IF Trump wins, he'll kick some FDA a$$
Dr. Califf is committed to strengthening programs and policies that enable the agency to carry out its mission to protect and promote the public health. I guess we shall see
Califf, chancellor of clinical and translational research at Duke University until recently, received money from 23 drug companies including the giants like Johnson & Johnson, Lilly, Merck, Schering Plough and GSK according to a disclosure statement on the website of Duke Clinical Research Institute.
Not merely receiving research funds, Califf also served as a high level Pharma officer, say press reports. Medscape, the medical website, discloses that Califf “served as a director, officer, partner, employee, advisor, consultant or trustee for Genentech.” Portola Pharmaceuticals says Califf served on its board of directors until leaving for the FDA.
Supposed to create competition and lower Healthcare costs, right ? IF Trump wins, he'll kick some FDA a$$
Dr. Califf is committed to strengthening programs and policies that enable the agency to carry out its mission to protect and promote the public health. I guess we shall see
Califf, chancellor of clinical and translational research at Duke University until recently, received money from 23 drug companies including the giants like Johnson & Johnson, Lilly, Merck, Schering Plough and GSK according to a disclosure statement on the website of Duke Clinical Research Institute.
Not merely receiving research funds, Califf also served as a high level Pharma officer, say press reports. Medscape, the medical website, discloses that Califf “served as a director, officer, partner, employee, advisor, consultant or trustee for Genentech.” Portola Pharmaceuticals says Califf served on its board of directors until leaving for the FDA.
(1)
(0)